Skip to content
PubMed This is a summary of 10 peer-reviewed journal articles Updated
Pulmonology · Nonspecific interstitial pneumonia

What Does “Nonspecific” Mean in an NSIP Diagnosis?

At a Glance

In an NSIP diagnosis, “nonspecific” does not mean unclear or imaginary. It describes a recognizable pattern of lung inflammation, scarring, or both, while further testing looks for causes such as autoimmune disease, medication effects, exposures, or infection.

When you hear the word “nonspecific,” it is completely natural to worry that your doctors are confused or just guessing about your condition. In everyday language, “nonspecific” often means vague or unclear. However, in the medical diagnosis of non-specific interstitial pneumonia (NSIP), the word means something very different. It does not mean your symptoms are imaginary or that your doctors don’t know what is happening in your lungs.

Instead, “nonspecific” refers to a specific, recognizable pattern of inflammation or scarring in the lungs. This pattern may be suggested by a high-resolution CT scan or confirmed if a lung biopsy is performed [1].

A Pattern, Not a Single Cause

To understand NSIP, it helps to think of it as a description of how your lungs are reacting, rather than why. The NSIP pattern is typically characterized by a relatively uniform distribution of inflammation, scarring (fibrosis), or a mix of both [2]. While fibrotic NSIP can involve structural changes in the lung, the pattern generally appears less patchy than what is seen in other forms of interstitial lung disease (ILD)—a broad category of diseases that cause lung scarring or inflammation—such as usual interstitial pneumonia (UIP) [3].

However, this recognizable pattern can be associated with several different underlying issues. It is called “nonspecific” because the pattern alone does not tell your doctor which of those issues triggered it [4]. The diagnosis is a starting point, not the final explanation.

Uncovering the Underlying Associations

Once an NSIP pattern is seen, the next step is to look for a possible underlying cause. Your care team will investigate several common categories:

  • Autoimmune and Connective-Tissue Diseases: Connective-tissue diseases are autoimmune illnesses that can affect joints, skin, muscles, or internal organs. Conditions like rheumatoid arthritis, systemic sclerosis (formerly commonly called scleroderma), Sjögren’s disease, polymyositis, or antisynthetase syndrome (a rare autoimmune disease affecting muscles and lungs) are frequently associated with the NSIP pattern [5][6].
  • Medications: Certain drugs can cause lung toxicity that results in an NSIP pattern [7]. (Note: Never stop taking a prescribed medication without first discussing it with your doctor. Suspected drug-related lung injury should be discussed promptly with your prescriber and lung specialist.)
  • Environmental or Occupational Exposures: Breathing in certain dusts, molds, chemicals, or bird proteins can prompt an immune reaction in the lungs [4]. While these exposures are carefully checked during a broad ILD evaluation, they may also point toward other conditions, such as hypersensitivity pneumonitis, rather than being the direct cause of NSIP.
  • Infections: Very rarely, certain infections or immune states, such as HIV, can be associated with developing this type of lung pattern [7]. Doctors may test for these selectively depending on your medical history, but an NSIP pattern by itself is not evidence that you have an infection.
  • Idiopathic NSIP: If a thorough investigation finds no underlying cause, the condition is called “idiopathic” (which means “of unknown cause”). This label is applied only after a rigorous evaluation [8]. Even then, doctors will continue to monitor you, as some people with idiopathic NSIP may develop a defined autoimmune disease years later [9]. However, this does not happen to everyone, and follow-up is individualized based on your symptoms. Blood tests are interpreted alongside your physical examination, and cannot alone confirm or rule out an autoimmune condition.

The Role of Multidisciplinary Review

Because determining the underlying cause of an NSIP pattern is complex, it is best evaluated through a multidisciplinary discussion [5]. This involves a team of specialists—typically a pulmonologist (lung doctor), a thoracic radiologist (imaging expert), a pathologist (tissue expert, if a biopsy was done), and sometimes a rheumatologist (autoimmune expert)—reviewing your case together [10]. They integrate your symptoms, medical history, blood tests, and scans into a complete picture.

This team approach can significantly improve diagnostic confidence and help guide treatment discussions. Because treatments depend on whether the NSIP is mostly inflammatory (cellular) or scarring (fibrotic), as well as what underlying cause is found, gathering expert input ensures a more personalized care plan.

Common questions in this guide

Does “nonspecific” mean my NSIP diagnosis is uncertain?
No. In NSIP, “nonspecific” describes a recognizable pattern of inflammation, scarring, or both in the lungs; it does not mean your symptoms are imaginary or that your doctors are guessing. The pattern does not identify the single underlying cause, so further evaluation may be needed.
Is NSIP a disease or a pattern?
NSIP is primarily a pattern of lung inflammation, scarring, or a mixture of both rather than one disease with one cause. It can be associated with autoimmune or connective-tissue disease, medications, environmental exposures, rare infections, or no identified cause.
How do doctors look for the cause of an NSIP pattern?
Doctors combine your symptoms, medical and medication history, exposure history, blood tests, and high-resolution CT findings; a lung biopsy may be considered in some cases. A pulmonologist, radiologist, pathologist, and sometimes rheumatologist may review the information together to improve diagnostic confidence.
What does idiopathic NSIP mean?
Idiopathic NSIP means that a thorough evaluation has not found an underlying cause. Doctors may continue individualized follow-up because some people later develop signs of an autoimmune disease, although this does not happen to everyone.
What is the difference between cellular and fibrotic NSIP?
Cellular NSIP is driven mainly by inflammation, while fibrotic NSIP has more lung scarring; some people have a mixed pattern. This distinction, along with the underlying cause, helps the care team discuss a personalized treatment plan.
Do I need a lung biopsy to diagnose NSIP?
Not everyone with a suspected NSIP pattern needs a biopsy. A high-resolution CT scan may suggest the pattern, and the decision to biopsy depends on how clear the scans and clinical information are, the possible benefit, and the risks for you; discuss it with your lung specialist.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on Non-specific interstitial pneumonia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What evidence supports my diagnosis—was the pattern seen on CT, a biopsy, or both, and is a biopsy necessary for me?
  2. 2.Has my case been reviewed by a multidisciplinary interstitial lung disease (ILD) board, or would a second opinion be helpful?
  3. 3.Based on my scans, is my NSIP pattern predominantly cellular (inflammation), fibrotic (scarring), or mixed?
  4. 4.What specific blood tests or evaluations should we do to check for an underlying autoimmune or connective-tissue disease?
  5. 5.If my NSIP is currently considered idiopathic, what specific symptoms of autoimmune disease should I watch for and report?

References

References (10)
  1. 1

    Nonspecific interstitial pneumonia: time to be more specific?

    Wells AU, Cottin V

    Current opinion in pulmonary medicine 2016; (22(5)):450-5 doi:10.1097/MCP.0000000000000302.

    PMID: 27428647
  2. 2

    Reprint of: Nonspecific interstitial pneumonia: pathologic features and clinical implications.

    Myers JL

    Seminars in diagnostic pathology 2018; (35(5)):334-338 doi:10.1053/j.semdp.2018.09.002.

    PMID: 30249370
  3. 3

    Meta-analysis of the radiological and clinical features of Usual Interstitial Pneumonia (UIP) and Nonspecific Interstitial Pneumonia (NSIP).

    Ebner L, Christodoulidis S, Stathopoulou T, et al.

    PloS one 2020; (15(1)):e0226084 doi:10.1371/journal.pone.0226084.

    PMID: 31929532
  4. 4

    Nonspecific Interstitial Pneumonia.

    Teoh AKY, Corte TJ

    Seminars in respiratory and critical care medicine 2020; (41(2)):184-201 doi:10.1055/s-0040-1708499.

    PMID: 32279290
  5. 5

    Histopathological significance of connective tissue disease-associated interstitial lung disease in transbronchial lung cryobiopsy specimens.

    Katsuragawa H, Sumiyoshi S, Ikegami N, et al.

    Pathology, research and practice 2024; (254()):155078 doi:10.1016/j.prp.2023.155078.

    PMID: 38262268
  6. 6

    Clinical, radiological, and pathological evaluation of "NSIP with OP overlap" pattern compared with NSIP in patients with idiopathic interstitial pneumonias.

    Enomoto N, Sumikawa H, Sugiura H, et al.

    Respiratory medicine 2020; (174()):106201 doi:10.1016/j.rmed.2020.106201.

    PMID: 33120192
  7. 7

    Pathophysiological Insights and Clinical Management Strategies for Interstitial Lung Diseases.

    Tian L, Wang Y, Qi W, et al.

    Biomolecules & therapeutics 2025; (33(5)):785-803 doi:10.4062/biomolther.2025.003.

    PMID: 40803754
  8. 8

    Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis.

    Fisher JH, Kolb M, Algamdi M, et al.

    BMC pulmonary medicine 2019; (19(1)):223 doi:10.1186/s12890-019-0986-4.

    PMID: 31771541
  9. 9

    Nonspecific interstitial pneumonia preceding diagnosis of collagen vascular disease.

    Kono M, Nakamura Y, Yoshimura K, et al.

    Respiratory medicine 2016; (117()):40-7.

    PMID: 27492512
  10. 10

    The role of vascularity and the fibrovascular interface in interstitial lung diseases.

    Dietrich J, Kang A, Tielemans B, et al.

    European respiratory review : an official journal of the European Respiratory Society 2025; (34(175)) doi:10.1183/16000617.0080-2024.

    PMID: 39909504

This page explains the meaning of “nonspecific” in an NSIP diagnosis for informational purposes only and does not constitute medical advice. Your pulmonologist and care team should interpret your scans, biopsy, tests, and possible causes for your individual situation.